Evid Invest
Who owns PCVXWhat PCVX owns — n/a

Who owns Vaxcyte, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of PCVX from SEC Form 13F filings across 357 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 357 institutions disclosed 169.9M shares of Vaxcyte, Inc. worth $9.67B — about 114.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

357

13F holders

$9.67B

value, 2026 filers

114.1%

of shares outstanding (169.9M sh)

69

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PCVX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC22.5M$1.28B0.1%15.1%+7.8%
2Janus Henderson Group Ltd.NEW17.9M$1.02B0.4%12%new
3T. Rowe Price Investment Management, Inc.14.3M$813.7M0.6%9.6%+17.1%
4BlackRock, Inc.12.2M$693.0M0.0%8.2%+0.9%
5RA CAPITAL MANAGEMENT, L.P.11.5M$652.9M6.5%7.7%0.0%
6WELLINGTON MANAGEMENT GROUP LLP7.7M$440.1M0.1%5.2%+10.5%
7VANGUARD CAPITAL MANAGEMENT LLC6.6M$373.9M0.0%4.4%+3.5%
8VANGUARD PORTFOLIO MANAGEMENT LLC6.6M$373.8M0.0%4.4%-0.4%
9STATE STREET CORP5.2M$297.7M0.0%3.5%-2.2%
10PRICE T ROWE ASSOCIATES INC /MD/3.5M$200.9M0.0%2.4%+18.1%
11Deep Track Capital, LP3.5M$199.9M3.3%2.4%-18.3%
12GEODE CAPITAL MANAGEMENT, LLC3.5M$198.9M0.0%2.3%+1.0%
13WESTFIELD CAPITAL MANAGEMENT CO LP3.3M$186.6M0.6%2.2%+32.6%
14Kynam Capital Management, LP2.6M$148.4M8.2%1.8%-10.8%
15GOLDMAN SACHS GROUP INC2.3M$132.7M0.0%1.6%+72.7%
16Bellevue Group AG2.3M$132.1M2.7%1.6%+17.8%
17Caligan Partners LP2.2M$124.5M7.6%1.5%0.0%
18Paradigm Biocapital Advisors LP2.1M$121.9M2.4%1.4%+0.7%
19CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.7M$95.7M0.0%1.1%+14.9%
20D. E. Shaw & Co., Inc.1.4M$81.4M0.0%1%-24.7%
21Pivotal bioVenture Partners Investment Advisor LLC1.4M$81.1M32.2%1%0.0%
22DIMENSIONAL FUND ADVISORS LP1.4M$80.9M0.0%1%+19.0%
23EVENTIDE ASSET MANAGEMENT, LLC1.4M$78.5M1.1%0.9%0.0%
24MAVERICK CAPITAL LTD1.4M$77.4M0.6%0.9%-15.7%
25NORTHERN TRUST CORP1.3M$72.6M0.0%0.9%-0.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.